'The name was inaccurate': PCOS gets a new name after years-long effort
Live Science • • general
Key Points:
- Polycystic ovary syndrome (PCOS), affecting 1 in 8 women, has been renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect the disease's hormonal and metabolic nature.
- The name change followed extensive global consultation involving thousands of patients, healthcare professionals, and 56 organizations, aiming for adoption over the next three years.
- The term "polycystic" was misleading, as the condition involves arrested follicles rather than true cysts, and the syndrome affects multiple bodily systems beyond the ovaries.
- The previous name contributed to misconceptions, underdiagnosis, and a narrow focus on reproductive issues, whereas the new name highlights the broader endocrine and metabolic disruptions.
- Future efforts include updating diagnostic language and addressing gaps in research and awareness, while experts caution against prematurely labeling a similar condition in males as PMOS.